Literature DB >> 16439049

Specific coping strategies of Africans during urbanization: comparing cardiovascular responses and perception of health data.

Leoné Malan1, Aletta Elisabeth Schutte, Nicolaas Theodor Malan, Maria Philipina Wissing, Hester Hendrina Vorster, Hendrik Stefanus Steyn, Johannes Marthinus van Rooyen, Hugo Willem Huisman.   

Abstract

Specific coping mechanisms of Africans during urbanization were compared to and correlated with cardiovascular responses and perception of health data. Subjects included men (N=286) and women (N=360). The COPE questionnaire classified subjects as active (AC) or passive (PC) copers and the General Health Questionnaire measured subjective perception of health. The Finapres recorded blood pressure continuously before and during application of a handgrip test. Analyses adjusting for age, body mass index and resting cardiovascular data revealed that AC rural subjects showed predominantly cardiac responses and PC rural subjects predominantly vascular responses. All urbanized African men and women showed higher resting blood pressure, vascular responsiveness and hypertension prevalences than their rural counterparts. All rural AC subjects, especially women, and all urban PC subjects, especially men, reported a poorer perception of health. In conclusion, subjects with a PC style showed a predominantly vascular response in rural and urban areas whereas subjects with an AC style seem to shift from a predominant cardiac output response to a predominant vascular resistance response when moving from a rural to an urban area.

Entities:  

Mesh:

Year:  2006        PMID: 16439049     DOI: 10.1016/j.biopsycho.2005.11.010

Source DB:  PubMed          Journal:  Biol Psychol        ISSN: 0301-0511            Impact factor:   3.251


  9 in total

1.  Attenuated NOx responses and myocardial ischemia, a possible risk for structural vascular disease in African men: the SABPA study.

Authors:  A S Uys; L Malan; J M van Rooyen; H S Steyn; M Reimann; T Ziemssen
Journal:  J Hum Hypertens       Date:  2014-01-09       Impact factor: 3.012

2.  Urbanicity affects blood pressure and heart rate reactivity to a speech stressor in Cameroon.

Authors:  Cheryl A Armstead; Norman B Anderson; Lucile L Adams-Campbell; James R Hébert; Walinjom F T Muna
Journal:  Ethn Dis       Date:  2010       Impact factor: 1.847

Review 3.  A systematic review of genetic influences on coping.

Authors:  Sandra H Dunn; Yvette P Conley
Journal:  Biol Res Nurs       Date:  2014-03-31       Impact factor: 2.522

4.  Chronic distress and acute vascular stress responses associated with ambulatory blood pressure in low-testosterone African men: the SABPA Study.

Authors:  N T Malan; T Stalder; M P Schlaich; G W Lambert; M Hamer; A E Schutte; H W Huisman; R Schutte; W Smith; C M C Mels; J M van Rooyen; L Malan
Journal:  J Hum Hypertens       Date:  2013-11-28       Impact factor: 3.012

5.  Coping and metabolic syndrome indicators in urban black South African men: the SABPA study.

Authors:  A du Plessis; L Malan; N T Malan
Journal:  Cardiovasc J Afr       Date:  2010 Sep-Oct       Impact factor: 1.167

6.  Cultural coping as a risk for depression and hypertension: the SABPA prospective study.

Authors:  S Le Roux; G A Lotter; H S Steyn; L Malan
Journal:  Cardiovasc J Afr       Date:  2018-08-22       Impact factor: 0.802

7.  Cardiovascular, cortisol and coping responses in urban Africans: the SAPBA study.

Authors:  D Meyburgh; L Malan; J M Van Rooyen; J C Potgieter
Journal:  Cardiovasc J Afr       Date:  2012-02       Impact factor: 1.167

8.  The cost of coping: a cardio-neuro-metabolic risk for black South Africans?

Authors:  L Malan; N T Malan; A Du Plessis; M P Wissing; J C Potgieter; Y K Seedat
Journal:  Cardiovasc J Afr       Date:  2010 Jul-Aug       Impact factor: 1.167

9.  Cohort Profile: Sympathetic activity and Ambulatory Blood Pressure in Africans (SABPA) prospective cohort study.

Authors:  Leoné Malan; Mark Hamer; Nancy Frasure-Smith; Hendrik S Steyn; Nicolaas T Malan
Journal:  Int J Epidemiol       Date:  2014-10-24       Impact factor: 7.196

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.